ExodusPoint Capital Management’s Assembly Biosciences ASMB Stock Holding History

ExodusPoint Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,880	Closed	-$53K	–	2177
2021 Q4	$53K	Buy	1,880 +262	+16%	+$8.59K	﹤0.01%	2023
2021 Q3	$68K	Sell	1,618 -4,585	-74%	-$192K	﹤0.01%	1946
2021 Q2	$289K	Buy	6,203 +4,957	+398%	+$246K	﹤0.01%	1767
2021 Q1	$69K	Buy	1,246 +175	+16%	+$11.6K	﹤0.01%	2009
2020 Q4	$78K	Buy	+1,071	New	+$126K	﹤0.01%	1855
2019 Q3	–	Sell	-1,692	Closed	-$274K	–	1323
2019 Q2	$274K	Buy	+1,692	New	+$322K	0.01%	744

Other funds holding ASMB

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AIM

Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ExodusPoint Capital Management's ASMB Position: Q1 2022 in Review

ExodusPoint Capital Management sold out of Assembly Biosciences (ASMB) in Q1 2022, closing a stake of 1,880 shares — an estimated $53K sold.

ExodusPoint Capital Management first reported a position in ASMB in Q2 2019 and held it in 6 quarters. The position peaked at $289K in Q2 2021. 54 funds tracked by Wall St. Rank hold ASMB as of Q1 2022.

ExodusPoint Capital Management reported no remaining Assembly Biosciences position as of Q1 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 1,880 Assembly Biosciences shares in Q1 2022, an estimated $53K.
ExodusPoint Capital Management first reported a position in Assembly Biosciences in Q2 2019 and held it in 6 quarters.
ExodusPoint Capital Management's Assembly Biosciences position peaked at $289K in Q2 2021.
54 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2022.

Based on ExodusPoint Capital Management's 13F filing for Q1 2022, filed 13 May 2022.